Pulse Biosciences Statistics
Total Valuation
PLSE has a market cap or net worth of $1.10 billion. The enterprise value is $1.00 billion.
Important Dates
The next confirmed earnings date is Wednesday, November 5, 2025, after market close.
| Earnings Date | Nov 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
PLSE has 67.30 million shares outstanding. The number of shares has increased by 11.07% in one year.
| Current Share Class | 67.30M |
| Shares Outstanding | 67.30M |
| Shares Change (YoY) | +11.07% |
| Shares Change (QoQ) | +0.22% |
| Owned by Insiders (%) | 73.65% |
| Owned by Institutions (%) | 8.98% |
| Float | 17.10M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 270.34 |
| PB Ratio | 10.34 |
| P/TBV Ratio | 10.94 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.05, with a Debt / Equity ratio of 0.08.
| Current Ratio | 12.05 |
| Quick Ratio | 11.85 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -103.50% and return on invested capital (ROIC) is -60.87%.
| Return on Equity (ROE) | -103.50% |
| Return on Assets (ROA) | -56.20% |
| Return on Invested Capital (ROIC) | -60.87% |
| Return on Capital Employed (ROCE) | -64.92% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$907,040 |
| Employee Count | 75 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +6.39% in the last 52 weeks. The beta is 1.79, so PLSE's price volatility has been higher than the market average.
| Beta (5Y) | 1.79 |
| 52-Week Price Change | +6.39% |
| 50-Day Moving Average | 17.06 |
| 200-Day Moving Average | 17.02 |
| Relative Strength Index (RSI) | 38.06 |
| Average Volume (20 Days) | 124,568 |
Short Selling Information
The latest short interest is 2.45 million, so 3.64% of the outstanding shares have been sold short.
| Short Interest | 2.45M |
| Short Previous Month | 2.49M |
| Short % of Shares Out | 3.64% |
| Short % of Float | 14.33% |
| Short Ratio (days to cover) | 10.73 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -72.24M |
| Pretax Income | -68.03M |
| Net Income | -68.03M |
| EBITDA | -71.10M |
| EBIT | -72.24M |
| Earnings Per Share (EPS) | -$1.07 |
Full Income Statement Balance Sheet
The company has $106.35 million in cash and $8.25 million in debt, giving a net cash position of $98.10 million or $1.46 per share.
| Cash & Cash Equivalents | 106.35M |
| Total Debt | 8.25M |
| Net Cash | 98.10M |
| Net Cash Per Share | $1.46 |
| Equity (Book Value) | 104.49M |
| Book Value Per Share | 1.55 |
| Working Capital | 99.18M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$44.50 million and capital expenditures -$239,000, giving a free cash flow of -$44.74 million.
| Operating Cash Flow | -44.50M |
| Capital Expenditures | -239,000 |
| Free Cash Flow | -44.74M |
| FCF Per Share | -$0.66 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PLSE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -11.07% |
| Shareholder Yield | -11.07% |
| Earnings Yield | -6.17% |
| FCF Yield | -4.06% |
Analyst Forecast
The average price target for PLSE is $22.00, which is 34.80% higher than the current price. The consensus rating is "Buy".
| Price Target | $22.00 |
| Price Target Difference | 34.80% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |